Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-12-11
1997-11-25
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548228, 5142368, 514340, 544137, 5462714, 930250, 530332, A61K 3142
Patent
active
056913680
ABSTRACT:
This invention relates to oxazolidine inhibitors of calpain and/or cathepsin B and to compositions containing them. As inhibitors of calpain and/or cathepsin B, the compounds are useful in the treatment of patients afflicted with acute or chronic neurodegenerative disorders.
REFERENCES:
patent: 3867364 (1975-02-01), Umezawa et al.
patent: 4277395 (1981-07-01), Bey et al.
patent: 4401594 (1983-08-01), Umezawa et al.
patent: 4535167 (1985-08-01), Freidinger
patent: 4820691 (1989-04-01), Patel
patent: 4845079 (1989-07-01), Luly et al.
patent: 4851387 (1989-07-01), Koike et al.
patent: 4990525 (1991-02-01), Young et al.
patent: 5081284 (1992-01-01), Higuchi et al.
patent: 5091575 (1992-02-01), Luly et al.
patent: 5142056 (1992-08-01), Kempe et al.
patent: 5214129 (1993-05-01), Luly et al.
patent: 5294720 (1994-03-01), Jadhav et al.
patent: 5416104 (1995-05-01), Hanson et al.
patent: 5444042 (1995-08-01), Bartus et al.
patent: 5496927 (1996-03-01), Kolb et al.
patent: 5510531 (1996-04-01), Higuchi et al.
Saito, et al., Agric Biol Chem 51, 861-868 (1987).
Ogura, et al., Agric Biol Chem 49, (3) 799-805, (1985).
Chemical Abstracts 100:19717u, vol. 100 (1984).
Smith, et al., Biochemistry 27, 6568-6573, (1988).
Saito, et al., Proc. Natl. Acad. Sci. USA, vol. 90, pp. 2628-2632, Apr. (1993).
Hong, et al., Stroke, vol. 25, No. 3, Mar. (1994).
Thompson, et al., Biochemistry, vol. 18, No. 8, 1552-1558, (1979).
Minami, et al., J. Neurosurg 76:111-118, (1992).
del Cerro, et al., Neuroscience Letters, 167, 149-152, (1994).
Caner,et al., Brain Research, 607, 354-356, (1993).
Siman, et al., The Journal of Neuroscience, 9(5):1579-1590, (1989).
Mehdi, et al., Bioch & Biophy Res. Communications, vol. 157, No. 3, (1988).
Mehdi, TIBS 16, Apr. 1991.
Saido, et al., FASEB 8:814-822 (1994).
Bundgaard, Hans, "Design of Bioreversible Drug Derivatives and the Utility of the Double Prodrug Concept", Bioreversible Carriers In Drug Design Theory and Application, Chapter 2, pp. 62-65 (1987).
Raddatz et al, "Renin Inhibitors Containing New P1-P1' Dipeptide mimetics with Heterocycles in P1'", J. Med. Chem., vol. 35, No. 19, 1992 pp. 3525-3536.
Peet et al, Synthesis of Peptidyl Fuuoromethyl Ketones and Peptidyl .alpha.-Keto Esters as Inhibitors of Procine Pancreatic Elastase, Human Neutrophil Elastase, and Rat and Human Neutrophil Cathepsin, G, J. Med Chem, 1990, 33, pp. 394-407.
Angelastro et al, J. Org. Chem. 54, pp. 3913-3916, (1989).
Mehdi, Bioorganic Chemistry, 21, pp. 249-259 (1993).
Angelastro et al, Bioorganic & Medicinal Chemistry Letters, vol. 2, No. 10, pp. 1235-1238 (1992).
J. Med. Chem. 33, pp. 11-13 (1990) "Communications to the Editor".
Minami, et al., "Effects of Inhibitors of Protein Kinase C and calpain in experimental delayed cerebral vasospasm", J Neurosurg 76:111-118, (1992).
del Cerro, et al., "Stimulation of NMDA receptors activates calpain in cultured hippocampal slices", Neuroscience Letters, 167, 149-152, (1994).
Caner, et al., "Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor", Brain Research, 607, 354-356, (1993).
Siman, et al., "Calpain I Activation is Specifically Related to Excitatory Amono Acid Induction of Hippocampal Damage", The Journal of Neuroscience, 9(5):1579-1590, (1989).
Mehdi, et al., "Inhibition of the Proteolysis of Rat Erythrocyte Membrane Proteins by a Synthetic Inhibitor of Calpain", Biochemical and Biophysical Research Communications, vol. 157, No. 3, (1988).
Mehdi, "Cell-Penetrating Inhibitors of Calpain", TIBS 16, Apr. 1991.
Saido, et al., "Calpain: new perspectives in molecular diversity and physiological-pathological involvement", FASEB 8:814-822 (1994).
Derwent Abst. 84-129431 (1984) Abstract Japan 58-164563A (1982).
Saito, et al., "Purification and structure of Novel Systeine Proteinase Inhibitors, Staccopins P1 and P2 from Staphylococcus tanabeensis", Agric Biol Chem 51, 861-868, (1987).
Ogura, et al., "Purification and Structure of a Novel Cysteine Proteinase Inhibitor, Strepin P-1", Agric Biol Chem 49, (3) 799-805, (1985).
Chemical Abstracts 100:19717u, vol. 100 (1984).
Smith, et al., "Inhibition of Cathepsin B By Peptidyl Aldehydes and Ketones: Slow-Binding Behavior of a Trifluoromethyl Ketone", Biochemistry 27, 6568-6573, (1988).
Saito, et al., "Widespread activation of caldium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuroal degeneration", Proc. Natl. Acad. Sci. USA, vol. 90, pp. 2628-2632, Apr. (1993).
Hong, et al., "Neuroprotection with a Calpain Inhibitor in a Model of Focal Cerebral Ischemia", Stroke, vol. 25, No. 3, Mar. (1994).
Thompson, et al., "Reaction of Peptide Aldehydes with Serine Proteases. Implications fo rhte Entropy Changes Associated with Enzymatic Catalysis", Biochemistry, vol. 18, No. 8, 1552-1558, (1979).
Mehdi, S., TIBS 16, pp. 150-153 (Apr. 1991).
Brorson, J., et al, Stroke, vol. 20, No. 7, pp. 1259-1267 (Jul. 1995).
Longa, E.Z., et al, Stroke, vol. 20, No. 1, pp. 84-91 (Jan. 1989).
Wang, K., Developing selective inhibitors of calpain; TIPS, Apr. 1990, vol. 11, pp. 139-142.
Hong et al, Stroke, vol. 25, No. 3 (Mar. 1994) pp. 663-669.
Peptides, Structure & Function, (Deber, C.M., et al), Proceedings of the American Peptide Symposium, Hori, H. et al, pp. 819-822, (1985).
Peptides, Structure & Function-Proceedings of the American Peptide Symposium (1985), Galpin, I.J. et al, pp. 799-802 Onyl pp. 799,801.
Zhaozhao Li et al, J. Med. Chem, 1993, 36, pp. 3472-3480.
Isabel Charles et al, J.C.S, Perkin I, 1980, pp. 1139-1146.
Angelastro Michael R.
Kim Hwa-Ok
Linnik Matthew D.
Mehdi Shujaath
Peet Norton P.
Daus Donald G.
Hoechst Marion Roussel Inc.
Sayles Michael J.
LandOfFree
Substituted oxazolidine calpain and/or cathepsin B inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted oxazolidine calpain and/or cathepsin B inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted oxazolidine calpain and/or cathepsin B inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107462